Zusammenfassung
Beim Screening (engl. »to screen« = sieben, sichten, überprüfen) werden möglichst alle (gesunden) Menschen einer bestimmten Alters- oder Bevölkerungsgruppe mit einer definierten Untersuchungsmethode auf das Vorhandensein einer Erkrankung hin untersucht. Ziel ist es, frühzeitig Krankheiten zu erkennen und zu behandeln, die noch nicht zu Beschwerden geführt haben. Damit soll die Lebensqualität der Erkrankten gebessert und möglichst auch die Mortalität gesenkt werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Advisory Committee on Cancer Prevention (2000) Recommendations on cancer screening in the European union. Eur J Cancer 36: 1473
AGO – Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. (2011a) Diagnostik und Therapie primärer und metastasierter Mammakarzinome. Früherkennung und Diagnostik. [www.ago-online.de/_download/unprotected/g_mamma_11_1_0_d_15_early_detection_diagnosis.pdf; Zugriff Juli 2011]
AGO – Arbeitsgemeinschaft Gynäkologische Onkologie, Kommission Mamma der Arbeitsgemeinschaft Gynäkologische Onkologie e.V (2011b) Diagnostik und Therapie primärer und metastasierter Mammakarzinome. Brustkrebsrisiko und Prävention. [www.ago-online.de/_download/protected/g_mamma_11_1_0_d_mem_16_breast_cancer_risk_prevention.pdf Zugriff Juli 2011]
Albert U-S, Altland H, Duda V, Engel J, Geraedts M, Heywang-Köbrunner S, Hölzel D, Kalbheim E, Koller M, König K, Kreienberg R, Kühn T, Lebeau A, Naß-Griegoleit I, Schlake W, Schmutzler R, Schreer I, Schulte H, Schulz-Wendtland R, Wagner U, Kopp I (2008) Stufe-3- Leitlinie Brustkrebs-Früherkennung in Deutschland [www.senologie.org/leitlinien.php; Zugriff Juli 2011]
Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A (1999) 14 years of followup from the Edinburgh randomised trial of breast-cancer screening. Lancet 353 : 1903–1908
Anderson I, Aspegren K, Janzon L et al. (1988) Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 297: 943–948
Armstrong K, Moye, E, WilliamsS et al. (2007) Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 146: 516
Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Héry C, Heanue M (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341: c3620
Baines, CJ, Dayan, R. A tangled web: Factors likely to affect the efficacy of screening mammography. J Natl Cancer Inst 1999; 91: 833
Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J (2003) Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen 10: 16–21
Barton MB, Harris R, Fletcher SW (1999) Does this patient have breast cancer? The screening clinical breast examination: Should it be done? How? JAMA 282: 1270
Bastardis-Zakas K, Iatrakis G, Navrozoglou I, Peitsidis P, Salakos N, Malakassis P, Zervoudis S (2010) Maximizing the benefits of screening mammography for women 40-49 years old. Clin Exp Obstet Gynecol 37: 278–282
Baxter N; Canadian Task Force on Preventive Health Care (2001) Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? Can Med Assoc J 164: 1837–1846
Becker N, Junkermann H (2008) Nutzen und Risiko des Mammographiescreenings. Dtsch Ärztebl 105(8) 131–6
Berrington de Gonzalez A, Reeves G (2005) Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits. Br J Cancer 93: 590
Berry DA, Cronin KA, Plevritis SK et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784
Bjurstam N, Björneld L, Warwick J, Sala E, Duffy SW, Nyström L, Walker N, Cahlin E, Eriksson O, Hafström LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Säve-Söderbergh J, Wahlin T (2003) The Gothenburg Breast Screening Trial. Cancer 97: 2387– 2396
Brewer NT, Salz T, Lillie SE (2007) Systematic review: The long-term effects of false-positive mammograms. Ann Intern Med 146: 502
Broeders MJ, Peer PG, Straatman H et al. (2001) Diverging breast cancer mortality rates in relation to screening? A comparison of Nijmegen to Arnhem and the Netherlands, 1969–1997. Int J Cancer 92 (2): 303–308
Buist DS, Anderson ML, Reed SD et al. (2009) Short-term hormone therapy suspension and mammography recall: a randomized trial. Ann Intern Med 150 :752
Carney PA, Miglioretti DL, Yankaskas BC et al. (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138: 168
Chlebowski RT, Hendrix SL, Langer RD et al.; WHI Investigators (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 289: 3243
Duffy SW, Tabár L, Chen HH et al. (2002) The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties. Cancer 95 (3): 458–469
Eddy DM (1989) Screening for breast cancer. Ann Intern Med 111: 389
Elmore JG, Armstrong K, Lehman CD, Fletcher SW (2005) Screening for breast cancer. JAMA 293: 1245–1256
Elmore, JG, Reisch LM, Barton MB et al. (2005) Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst 97: 1035
Ernster VL, Barclay J, Kerlikowske K et al. (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913
Feig SA (2004) Screening strategy for breast cancer. Sem Breast Disease 6: 161–172
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765– 781
Freedman DA, Petitti DB, Robins JM (2004) On the efficacy of screening for breast cancer. Int J Epidemiol 33: 43–55
Frisell J, Eklund G, Hellström L, Lidbrink E, Rutqvist LE, Somell A (1991) Randomized study of mammography screening--preliminary report on mortality in the Stockholm trial. Breast Cancer Res Treat 18: 49–56
Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE (1997) Follow-up after 11 years – update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 45: 263–270
GBA (2011) Richtlinie des Gemeinsamen Bundesausschusses über die Früherkennung von Krebserkrankungen (Krebsfrüherkennungs- Richtlinie/KFE-RL) in der Fassung vom 18. Juni 2009 veröffentlicht im Bundesanzeiger 2009, Nr. 148a in Kraft getreten am 3. Oktober 2009, zuletzt geändert am 16. Dezember 2010, veröffentlicht im Bundesanzeiger 2011; Nr. 34: S. 864, in Kraft getreten am 3. März 2011 [www.g-ba.de/downloads/62-492-510/RL_KFU_2010-12-16.pdf; Zugriff Juli 2011]
Gordon PB (2002) Ultrasound for breast cancer screening and staging. Radiol Clin N Am 40: 431–441
Gøtzsche PC, Nielsen M (2009) Screening for breast cancer with mammography. Cochrane Database Syst Rev (4): CD001877
Gronwald J, Pijpe A, Byrski T et al. (2008) Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 112: 581
Hackshaw A (2003) EUSOMA review of mammography screening. Ann Oncol 14: 1193–1195
Hackshaw AK, Paul EA (2003) Breast self-examination and death from breast cancer: a meta-analysis. Br J Cancer 88: 1047
Hambly NM, McNicholas MM, Phelan N, Hargaden GC, O'Doherty A, Flanagan FL (2009) Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program. Am J Roentgenol 193: 1010–1018
Harris R, Leininger L (1995) Clinical strategies for breast cancer screening: weighing and using the evidence. Ann Intern Med 122 (7): 539–547
Harvey JA, Pinkerton JV, Herman CR (1997) Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst 89: 1623
Hendrick RE, Smith RA, Rutledge JH, Smart CR (1997) Benefit of screening mammography in women aged 40–49: a new metaanalysis of randomized controlled trials. J Natl Cancer Inst Monogr 22: 87–92
Hofvind S, Vacek PM, Skelly J, Weaver DL, Geller BM (2008) Comparing screening mammography for early breast cancer detection in Vermont and Norway. J Natl Cancer Inst 100: 1082–1091
Hulka BS, Moorman PG (2008) Breast cancer: hormones and other risk factors. Maturitas 61: 203–213
Humphrey LL, Helfand M, Chan BK, Woolf SH (2002) Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137: 347
IARC Handbooks of Cancer Prevention, Vol. 7: Breast Cancer Screening, eds. H. Vainio and F. Bianchini, IARC Press, Lyon 2002 [www.iarc.fr/en/publications/pdfs-online/prev/handbook7/Handbook7_Breast-0.pdf ]
Irwig L, Houssami N, van Vliet C (2004) New technologies in screening for breast cancer: a systematic review of their accuracy. Br J Cancer 90: 2118–2122
Jatoi I (2003) Screening clinical breast examination. Surg Clin North Am 83: 789–801
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69–90
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225–49
Jonsson H, Nyström L, Törnberg S et al. (2001) Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer. J Med Screen 8 (3): 152–160
Karssemeijer N, Bluekens AM, Beijerinck D, Deurenberg JJ, Beekman M, Visser R, van Engen R, Bartels-Kortland A, Broeders MJ (2009) Breast cancer screening results 5 years after introduction of digital mammography in a population-based screening program. Radiology 253 (2): 353–358 [Epub ahead of print 2009 Sep 29]
Kerlikowske K, Salzmann P, Phillips KA et al. (1999) Continuing screening mammography in women aged 70 to 79 years. Impact on life expectancy and cost-effectiveness. JAMA 282: 2156
Kooperationsgemeinschaft Mammographie (2009) Evaluationsbericht 2005–2007. [www.mammo-programm.de/cms_upload/datenpool/evaluationsbericht05-07_web.pdf ]
Kooperationsgemeinschaft Mammographie (2010) Qualitätsbericht 2005–2007. [www.mammo-programm.de/cms_upload/datenpool/qualitaetsbericht_web.pdf ]
Kornguth PJ, Rimer BK, Conaway MR et al. (1993) Impact of patientcontrolled compression on the mammography experience. Radiology 186: 99
Kösters JP, Gøtzsche PC (2003) Regular self-examination or clinical examination for early detection of breast cancer. Cochrane Database Syst Rev CD003373
Martin LJ, Minkin S, Boyd NF (2009) Hormone therapy, mammographic density, and breast cancer risk. Maturitas 64: 20–26
Miller AB, Baines CJ, To T et al. (1992) Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 147 (10): 1477–1488
Miller AB, To T, Baines CJ, Wall C (2000) Canadian National Breast Screening Study 2: 13-year results of a randomized trial in women aged 50–59 years. J Natl Cancer Inst 92: 1490
Miller AB, To T, Baines CJ et al. (2002) The Canadian National Breast Screening Study 1: Breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 137 (5 Part 1): 305– 312
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L; Trial Management Group (2006) Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 368: 2053–2060
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, Humphrey L (2009) Screening for Breast Cancer: Systematic Evidence Review Update for the US Preventive Services Task Force [Internet]. Agency for Healthcare Research and Quality (US) Report No 10- 05142-EF-1. [www.ncbi.nlm.nih.gov/books/NBK36392/]
Nyström L, Rutqvist LE, Wall S et al. (1993) Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 341 (8851): 973–978
Nyström L, Andersson I, Bjurstam N et al. (2002) Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359: 909
O'Driscoll D, Warren R, MacKay J, Britton P, Day NE (2001) Screening with breast ultrasound in a population at moderate risk due to family history. J Med Screen 8: 106–109
Okonkwo QL, Draisma G, der Kinderen A et al. (2008) Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 100: 1290
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. [www.screening.iarc.fr/doc/ND7306954ENC_002.pdf; Zugriff Juli 2011]
Pharoah PD, Antoniou AC, Easton DF, Ponder BA (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358: 2796
Pisano ED, Gatsonis C, Hendrick E et al.; Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group (2005) Diagnostic performance of digital versus film mammography for breastcancer screening. N Engl J Med 353: 1773
Rajkumar SV, Hartmann LC (1999) Screening mammography in women aged 40–49 years. Medicine (Baltimore) 78: 410
Ravdin PM, Cronin KA, Howlader N et al. (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356: 1670
Roberts MM, Alexander FE, Anderson TJ et al. (1990) Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 335: 241–246
Saslow D, Boetes C, Burke W et al. (2007) American Cancer Society guidelines for breast cancer screening with MRI as an adjunct to mammography. CA Cancer J Clin 57: 75
Scharl A (2010) Brustkrebsfrüherkennung nach dem 69. Lebensjahr. Geburtsh Frauenheilkd 70: 832–834
Schonberg MA, Silliman RA, Marcantonio ER (2009) Weighing the benefits and burdens of mammography screening among women age 80 years or older. J Clin Oncol 27: 1774
Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45: 1916
Shapiro S, Venet W, Strax P, Venet L, Roeser R (1982) Ten- to fourteenyear effect of screening on breast cancer mortality. J Natl Cancer Inst 69: 349–355
Shapiro S, Venet V, Strax P, Venet L, Roeser R (1985) Selection, followup and analysis in the Health Insurance Plan Study: a randomised trial with breast cancer screening. J Natl Cancer Inst Monogr 67: 65–74
Shen Y, Parmigiani G (2005) A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations. Cancer Epidemiol Biomarkers Prev 14: 529–532
Skaane P, Skjennald A (2004) Screen-film mammography vs. full-field digital mammography with soft-copy reading: randomized trial in a population-based screening program – the Oslo II Study. Radiology 232: 197
Tabàr L, Fagerberg G, Duffy SW, Day NE, Gad A, Gröntoft O (1992) Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 30 (1): 187– 210
Thomas DB, Gao DL, Ray RM, Wang WW, Allison CJ, Chen FL, Porter P, Hu YW, Zhao GL, Pan LD, Li W, Wu C, Coriaty Z, Evans I, Lin MG, Stalsberg H, Self SG (2002) Randomized trial of breast self-examination in Shanghai: final results. J Natl Cancer Inst 94: 1445– 1457
Thomssen C (2011) Level of Evidence (LoE), Grade of Recommendation (GR) und AGO-Empfehlungsgrade. In AGO Kommission Mamma (Hrsg) Aktuelle Empfehlungen zur Prävention, Diagnostik und Therapie primärer und fortgeschrittener Mammakarzinome – State of the Art 2011. München: Zuckschwerdt, S XVII
U.S. Preventive Services Task Force – USPSTF (2009) Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 151: 716–726
Van Dijck JA, Verbeek AL, Beex LV et al. (1996) Mammographic screening after the age of 65 years: Evidence for a reduction in breast cancer mortality. Int J Cancer 66: 727
Van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJM, Verbeek ALM (2010) Effective biennial mammographic screening in women aged 40–49 years. Eur J Cancer 3137: 3140
Verbeek AL, Hendriks JH, Holland R et al. (1984) Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975–1981. Lancet i (8388): 1222–1224
Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, Dos Santos Silva IM (2009) Full-field digital vs. screen-film mammography: comparison within the UK breast screening program and systematic review of published data. Radiology 251: 347–358
Walter LC, Covinsky KE (2001) Cancer screening in elderly patients. A framework for individualized decision making. JAMA 285: 2750
Warner E, Plewes DB, Shumak RS et al. (2001) Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 19: 3524–3531
Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148: 671–679
Weiss NS (2003) Breast cancer mortality in relation to clinical breast examination and breast self-examination. Breast J 9 Suppl 2: 86–89
Welch HG, Woloshin S, Schwartz LM (2008) The sea of uncertainty surrounding ductal carcinoma in situ – the price of screening mammography. J Natl Cancer Inst 100: 228
White E, Velentgas P, Mandelson MT et al. (1998) Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 years. J Natl Cancer Inst 90: 906
Zahl PH, Strand BH, Maehlen J (2004) Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ 328: 921
Zahl PH, Maehlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med 168: 2311
Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K (2003) Mammographic breast density and family history of breast cancer. J Natl Cancer Inst 95: 556
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scharl, A., Göhring, UJ. (2013). Mammographiescreening. In: Kaufmann, M., Costa, S.D., Scharl, A. (eds) Die Gynäkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-20923-9_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-20923-9_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-20922-2
Online ISBN: 978-3-642-20923-9
eBook Packages: Medicine (German Language)